SCHEDULE: State Street Reports 5.3% Stake in Myriad Genetics

State Street Corporation has disclosed beneficial ownership of 5.3% of Myriad Genetics Inc. common stock as of June 30, 2026.

Summary

• State Street Corporation, through its subsidiaries, now beneficially owns 4,985,060 shares of Myriad Genetics Inc. common stock.
• This represents 5.3% of the class of securities.
• The filing is made under Schedule 13G, indicating passive investment.
• The reporting date for this ownership level is June 30, 2026.
• State Street Corporation is identified as a 'HC' (likely meaning Holding Company or similar institutional classification) type of reporting person.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership percentage without indicating new strategic initiatives or significant financial performance changes.

Positives

• State Street Corporation's increased stake may signal confidence in Myriad Genetics' long-term prospects from a major institutional investor.
• The filing indicates a significant institutional holding, which can sometimes lead to increased liquidity and analyst coverage.

Negatives

• The filing does not provide details on the specific reasons for the change in beneficial ownership, leaving room for speculation.
• A passive stake does not necessarily translate to active support or influence on company strategy.

Risks

• The passive nature of the investment means State Street Corporation is not actively seeking to influence control, limiting potential positive impact from their involvement.
• Future changes in State Street's holdings could impact Myriad Genetics' stock price due to the size of the stake.

Future Outlook

This filing is a snapshot of beneficial ownership and does not contain forward-looking statements or guidance from Myriad Genetics Inc.

Industry Context

StockSavvy.ai notes that institutional filings like this are common in the biotechnology and healthcare sectors, reflecting the significant capital required for research and development. State Street Corporation is a major global custodian and investment management firm, and its holdings often reflect broad market trends or specific sector attractiveness.

Stakeholder Impact

• Shareholders: The increased stake by a large institutional investor could be perceived positively, potentially influencing investor sentiment. However, the passive nature of the holding limits direct impact on corporate strategy.
• Management: May see increased engagement from State Street Corporation's investor relations, but no direct strategic influence is implied by this filing.
• Creditors: No direct impact is indicated by this ownership filing.

Next Steps

• Monitor future filings from State Street Corporation for any changes in their beneficial ownership of Myriad Genetics Inc.

Key Dates

Keywords

Myriad Genetics, State Street Corporation, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Ownership Stake